AzTrials
AzTrials

Intubation DifficultPhase 4NCT02286570

Face-to-face Tracheal Intubation: a Comparison of Airtraq, Glidescope and Fastrach

A Phase 4 study testing Glidescope, Airtraq and Fastrach in people with Intubation Difficult, run by Kocaeli University.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Trauma victims had to be intubated at the scene of area in different conditions. Face-to-face intubation in an entrapped patient is one of these situations. The investigators want to compare the efficacy of Glidescope, Airtraq and Fastrach in simulating face-ro-face intubation in adult patients aged between 18-60… Read more about this study

Who is it for?
Ages 18 to 60 years
Conditions the study is for
Intubation Difficult
What is being tested?
Glidescope, Airtraq and Fastrach
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
120 participants
Where
No sites listed yet
Study dates
Oct 2014to Jan 2015
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • 18-60 years of age
  • Elective surgery requiring endotracheal intubation
  • Normal airway variables
  • BMI< 30

Who cannot join

  • < 18 years or > 60 years
  • Emergency procedures
  • Known difficult airways
  • BMI> 30

About this study

Official title: Face-to-face Tracheal Intubation With Fastrach or Videolaryngoscopes

Trauma victims had to be intubated at the scene of area in different conditions. Face-to-face intubation in an entrapped patient is one of these situations. The investigators want to compare the efficacy of Glidescope, Airtraq and Fastrach in simulating face-ro-face intubation in adult patients aged between 18-60 years.

Read the detailed description

The investigators record the demographic and the airway data of the patients (thyromental distance, sternomental distance, mallampati score, mandibula protrusions, interincisor distance..etc). The hemodynamic data of the patients baseline preoperatively, after induction, after insertion of the device, after intubation, and 2 minutes intervals after intubation during the ten minutes. Cormack-Lehane grade of the videolaryngoscopes, insertion time, intubation time, need of optimisation maneuvers, mucosal damage, teeth and tongue damage, postoperative sore throat, hoarseness, dysphagia were recorded.

Being tested
Glidescope, Airtraq, Fastrach

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • GlidescopeDevice

    videolaryngoscope used for endotracheal intubation

  • AirtraqDevice

    videolaryngoscope used for endotracheal intubation

  • FastrachDevice

    intubating laryngeal mask airway used for blind endotracheal intubation

Study groups in NCT02286570
Study groupRoleWhat they receive
face-to-face intubation of GlidescopeActive comparatorpatients were intubated using glidescope by face-to-face approach
Receives: Device: Glidescope
face-to-face intubation with AirtraqActive comparatorpatients were intubated using the Airtraq by face-to-face approach
Receives: Device: Airtraq
face-to-face intubation with fastrachActive comparatorpatients were intubated using the Fastrach by face-to-face approach
Receives: Device: Fastrach

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. intubation time

    2 minutes

    Measured: elapsing between the handling of the device till intubation 2 minutes

Secondary outcomes (4)
  1. mucosal damage

    1 minute after removal

    Measured: blood on the device after removal 1 minute

  2. postoperative minor complications sore troat, teeth damage, tongue damage, desaturation, hoarseness, disphagia

    30 minutes after extubation

    Measured: sore troat, teeth damage, tongue damage, desaturation, hoarseness, disphagia 30 minutes

  3. need of optimisation maneuvers

    during 15 minutes while intubation

    Measured: chandy, side-to-side, handling force, up-down, reinserting 15 minutes

  4. hemodynamic changes (mean arteriial pressure)

    mmHg

    Measured: entübation and after 15 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Nov 2014 (estimated)
  2. Study startOct 2014
  3. Primary completionDec 2014
  4. Study completionJan 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
120 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02286570
Sponsor's protocol ID
KOU KAEK 2014/255
Status last verified
Mar 2015
First submitted
31 Oct 2014
Last updated
1 Apr 2015
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing Glidescope, Airtraq and Fastrach in people with Intubation Difficult, run by Kocaeli University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Apr 2015. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

intubation time (time frame: elapsing between the handling of the device till intubation 2 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Apr 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in